Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients
{{output}}
Background: Metastatic breast cancer (MBC) is a major health problem worldwide. Some patients improve on tamoxifen and others do not respond to treatment. Therefore, the aim of the current study is to assess genetic aberrations i... ...
